Quantitative high-resolution genomic analysis of single cancer cells

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Hannemann, Juliane ^a   Meyer Staeckling, Sönke ^a   Kemming, Dirk ^a,d   Alpers, Iris ^a   Joosse, Simon A ^a   Pospisil, Heike ^b,c   Kurtz, Stefan ^b   Görndt, Jennifer ^b   Püschel, Klaus ^b   Riethdorf, Sabine ^a   Pantel, Klaus ^a   Brandt, Burkhard ^a,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c TECHNICAL UNIVERSITY OF APPLIED SCIENCES WILDAU   (Germany)

^d European Laboratory Association   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW; BREAST CANCER; CANCER CELL; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; COPY NUMBER VARIATION; EGFR GENE; GENE; GENE AMPLIFICATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; MICROMANIPULATION; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; BLOOD; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC HETEROGENEITY; GENETICS; GENOMICS; METHODOLOGY; NEOPLASM; PATHOLOGY; SINGLE CELL ANALYSIS; TUMOR CELL LINE;

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR;

CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC HETEROGENEITY; GENOMICS; HUMANS; NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SINGLE-CELL ANALYSIS;

EID: 82355170196     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026362     Document Type: Article

References (22)

1. Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B, (2010) EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 1: 497-514.
2. Dienstmann R, Martinez P, Felip E, (2011) Personalizing therapy with targeted agents in non-small cell lung cancer. Oncotarget 2: 165-77.
3. Hirsch FR, Bunn PA Jr, (2009) EGFR testing in lung cancer is ready for prime time. Lancet Oncol 10: 432-433.
4. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, et al. (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359: 366-377.
5. Pantel K, Brakenhoff RH, Brandt B, (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340.
6. Agelopoulos K, Buerger H, Brandt B, (2008) Allelic imbalances of the egfr gene as key events in breast cancer progression-the concept of committed progenitor cells. Curr Cancer Drug Targets 8: 431-445.
7. Agelopoulos K, Greve B, Schmidt H, Pospisil H, Kurtz S, et al. (2010) Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468. BMC Cancer 10: 78.
8. Dean FB, Hosono S, Fang L, Wu X, Faruqi AF, et al. (2002) Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A 99: 5261-5266.
9. Spits C, Le CC, De RM, Van HL, Van SA, et al. (2006) Whole-genome multiple displacement amplification from single cells. Nat Protoc 1: 1965-1970.
10. Tidow N, Boecker A, Schmidt H, Agelopoulos K, Boecker W, et al. (2003) Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development. Cancer Res 63: 1172-1178.
11. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, et al. (2005) High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7: R1186-R1198.
12. Eilers PH, de Menezes RX, (2005) Quantile smoothing of array CGH data. Bioinformatics 21: 1146-1153.
13. Moroni M, Veronese S, Benvenuti S, Marrapese G, Sartore-Bianchi A, et al. (2005) Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 6: 279-286.
14. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, et al. (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353: 793-802.
15. Morrison BJ, Schmidt CW, Lakhani SR, Reynolds BA, et al. (2008) Breast cancer stem cells: implications for therapy of breast cancer. Breast Cancer Res 10: 210 bcr2111 [pii];10.1186/bcr2111 [doi].
16. Duncan CG, Killela PJ, Payne CA, Lampson B, Chen WC, et al. (2010) Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes. Oncotarget 1: 265-277.
17. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679 djn123 [pii];10.1093/jnci/djn123 [doi].
18. Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, et al. (2008) The CD44+/. Breast Cancer Res 10: R53 bcr2108 [pii];10.1186/bcr2108 [doi].
19. Stoecklein NH, Hosch SB, Bezler M, Stern F, Hartmann CH, et al. (2008) Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13: 441-453.
20. Fuhrmann C, Schmidt-Kittler O, Stoecklein NH, Petat-Dutter K, Vay C, et al. (2008) High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. Nucleic Acids Res 36: e39 gkn101 [pii];10.1093/nar/gkn101 [doi].
21. Allison M, (2010) The HER2 testing conundrum. Nat Biotechnol 28: 117-119.
22. Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, et al. (2005) Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44: 305-319.